Logo image of EPZM

EPIZYME INC (EPZM) Stock Analyst Ratings

NASDAQ:EPZM - Nasdaq - US29428V1044 - Common Stock - Currency: USD

1.47  -0.02 (-1.34%)

After market: 1.47 0 (0%)

Buy % Consensus

78

ChartMill assigns a Buy % Consensus number of 78% to EPZM. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 3.04. This target is 107% above the current price.
EPZM was analyzed by 9 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about EPZM.
In the previous month the buy percentage consensus was at a similar level.
EPZM was analyzed by 9 analysts. More opinions would make the average more meaningful.

Related screens

EPZM Historical Analyst RatingsEPZM Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -68 -62 -56 -50 -44 -38 -32 -26 -20 -14 -8 -2 5 10 15

Price Target & Forecast

Price Low Median Mean High 1.471.461.533.046.30 - -0.37% 4.08% 107.00% 328.57%

Related screens

EPZM Current Analyst RatingEPZM Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0
Up and Down Grades
Date Firm Action Rating
2022-06-28 Cowen & Co. Downgrade Outperform -> Market Perform
2022-06-27 Wedbush Downgrade Outperform -> Neutral
2022-06-03 HC Wainwright & Co. Maintains Buy
2022-05-12 HC Wainwright & Co. Maintains Buy
2022-03-02 HC Wainwright & Co. Maintains Buy
2021-08-10 Morgan Stanley Downgrade Equal-Weight -> Underweight
2021-08-10 HC Wainwright & Co. Maintains Buy
2021-05-07 SVB Leerink Upgrade Market Perform -> Outperform
2021-05-07 Morgan Stanley Maintains Equal-Weight
2021-04-19 Morgan Stanley Maintains Equal-Weight
2021-03-31 Credit Suisse Initiate Outperform
2021-02-25 Morgan Stanley Downgrade Overweight -> Equal-Weight